Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
Work
Year: 2013
Type: article
Abstract: Amplifications and mutations in the KIT proto-oncogene in subsets of melanomas provide therapeutic opportunities.We conducted a multicenter phase II trial of imatinib in metastatic mucosal, acral, or ... more
Source: Journal of Clinical Oncology
Authors F. Stephen Hodi, Christopher L. Corless, Anita GiobbieâHurder, Jonathan A. Fletcher, Meijun Zhu +19 more
Institutions Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Massachusetts General Hospital, Oregon Health & Science University, Harvard University Press +7 more
Cites: 32
Cited by: 554
Related to: 10
FWCI: 25.31
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze